Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Condition:   Primary Adrenal Insufficiency
    Intervention:   Diagnostic Test: Cosyntropin stimulation test
    Sponsors:   University of Bergen;   Karolinska Institutet;   Charite University, Berlin, Germany
    Recruiting

  • Conditions:   Hyperaldosteronism;   Angiography
    Intervention:   Procedure: Adrenal Venous Sampling
    Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital
    Recruiting

  • Condition:   ALD (Adrenoleukodystrophy)
    Interventions:   Other: Medical Record Abstraction;   Other: Biospecimen Sample Collection
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Not yet recruiting

  • Conditions:   Primary Aldosteronism;   Stroke
    Intervention:   Diagnostic Test: Aldosterone renin ratio
    Sponsor:   Changi General Hospital
    Recruiting

  • Condition:   Adrenal Insufficiency
    Intervention:   Drug: Cosyntropin
    Sponsor:   Johns Hopkins University
    Not yet recruiting

  • Condition:   Congenital Adrenal Hyperplasia
    Interventions:   Drug: Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone);   Drug: Dual release hydrocortisone (plenadren)
    Sponsor:   Federico II University
    Recruiting

  • Conditions:   Congenital Adrenal Hyperplasia;   Hyperplasia;   Adrenal Hyperplasia;   Congenital Disorders;   Adrenocortical Hyperfunction;   Disorders of Sex Development;   Urogenital Abnormalities;   Genetic Diseases, Inborn;   Steroid Metabolic Diseases, Inborn;   Adrenal Gland Disease;   Hydrocortisone
    Interventions:   Drug: Subcutaneous hydrocortisone;   Drug: Standard glucocorticoid therapy
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   FDA Office of Orphan Products Development
    Not yet recruiting

  • Condition:   X-linked Adrenoleukodystrophy
    Intervention:   Genetic: Intracerebral LV gene therapy
    Sponsor:   Shenzhen Geno-Immune Medical Institute
    Recruiting

  • Condition:   Adrenocortical Carcinoma
    Interventions:   Drug: Cisplatin plus Etoposide;   Other: Observation or Mitotane
    Sponsor:   Azienda Ospedaliera Spedali Civili di Brescia
    Recruiting

  • Conditions:   Adrenal Insufficiency;   Osteopenia, Osteoporosis;   Steroid Suppression of ACTH Secretion
    Interventions:   Drug: Low Dose Cosyntropin (ACTH) stimulation test;   Drug: High Dose Cosyntropin (ACTH) stimulation test
    Sponsor:   Nationwide Children's Hospital
    Recruiting

  • Condition:   Cushing Syndrome
    Interventions:   Drug: Relacorilant;   Other: Placebo
    Sponsor:   Corcept Therapeutics
    Recruiting

  • Condition:   Haematological Malignancy
    Intervention:   Other: Hydrocortisone supplementation
    Sponsor:   Rennes University Hospital
    Not yet recruiting

  • Conditions:   Congenital Adrenal Hyperplasia;   CAH - Congenital Adrenal Hyperplasia;   CAH - 21-Hydroxylase Deficiency
    Intervention:   Drug: SPR001
    Sponsor:   Spruce Biosciences
    Recruiting

  • Conditions:   Cushing Syndrome;   Acromegaly
    Intervention:   Other: MRI, dual-energy, x-ray absorptiometry, muscle ultrasounds, blood testing
    Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
    Recruiting

  • Condition:   Congenital Adrenal Hyperplasia
    Intervention:   Drug: Nevanimibe hydrochloride
    Sponsor:   Millendo Therapeutics US, Inc.
    Recruiting

  • Conditions:   Primary Aldosteronism;   Hypertension
    Interventions:   Procedure: Endovascular chemical Ablation of Adrenal Gland;   Drug: Sequenced antihypertensvie drugs with titrated dosage
    Sponsor:   Third Military Medical University
    Recruiting

  • Condition:   Adrenal Insufficiency
    Intervention:  
    Sponsors:   Imperial College London;   National Institute for Health Research, United Kingdom
    Recruiting

  • Condition:   Adrenal Insufficiency
    Intervention:   Other: There is no specific intervention other than an individual changing their treatment as part of their usual care
    Sponsor:   Imperial College London
    Recruiting

  • Condition:   Hypercorticism
    Interventions:   Other: Questionnaires of life quality for patients;   Other: Questionnaires of life quality for caregivers
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Recruiting

  • Condition:   Cushing Syndrome
    Intervention:   Drug: relacorilant
    Sponsor:   Corcept Therapeutics
    Recruiting

  • Condition:   Cushing's Syndrome
    Intervention:   Drug: osilodrostat
    Sponsor:   Novartis Pharmaceuticals
    Recruiting

  • Conditions:   Cushing Syndrome;   Cushing Disease
    Intervention:   Drug: Levoketoconazole
    Sponsor:   Cortendo AB
    Not yet recruiting

  • Condition:   Adrenocortical Carcinoma
    Intervention:   Drug: Cabozantinib-s-malate
    Sponsor:   Wuerzburg University Hospital
    Not yet recruiting

  • Conditions:   Resistant Hypertension;   Adrenal Disease
    Interventions:   Procedure: unilateral laparoscopic adrenalectomy;   Drug: standard medical treatment
    Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital
    Not yet recruiting

  • Condition:   Adrenal Hyperplasia, Congenital
    Intervention:  
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting

  • Conditions:   ENSAT Stage I Adrenal Cortex Carcinoma;   ENSAT Stage II Adrenal Cortex Carcinoma;   ENSAT Stage III Adrenal Cortex Carcinoma
    Interventions:   Drug: Cisplatin;   Drug: Etoposide;   Drug: Mitotane;   Procedure: Quality-of-Life Assessment
    Sponsors:   M.D. Anderson Cancer Center;   Amercian Australian Asian Adrenal Alliance (A5);   European Network for the Study of Adrenal Tumors (ENS@T)
    Recruiting

  • Condition:   Congenital Adrenal Hyperplasia (CAH)
    Intervention:  
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Recruiting

  • Condition:   Congenital Adrenal Hyperplasia
    Interventions:   Drug: Abiraterone acetate;   Drug: Placebo;   Drug: Hydrocortisone;   Drug: Fludrocortisone
    Sponsors:   University of Texas Southwestern Medical Center;   National Institutes of Health Clinical Center (CC);   University of Michigan;   Children's Hospital Los Angeles;   Feinstein Institute for Medical Research
    Not yet recruiting

  • Conditions:   Aldosterone Disorder;   Adrenal Gland Disease;   Blood Pressure
    Interventions:   Dietary Supplement: Sodium loaded diet;   Dietary Supplement: Restricted sodium diet;   Drug: Angiotensin II;   Drug: Para-Aminohippurate
    Sponsors:   Brigham and Women's Hospital;   National Institutes of Health (NIH)
    Recruiting

  • Condition:   CAH - Congenital Adrenal Hyperplasia
    Intervention:   Drug: NBI-74788
    Sponsor:   Neurocrine Biosciences
    Recruiting

  • Conditions:   Adrenal Adenoma;   Cushing Syndrome;   Pheochromocytoma;   Adrenal Incidentaloma;   Adrenocortical Carcinoma;   Primary Hyperaldosteronism
    Intervention:   Other: Hormone study and Imaging study
    Sponsor:   Seoul National University Hospital
    Not yet recruiting

  • Condition:   Diagnosis of Primary Aldosteronism
    Intervention:   Other: no intervention
    Sponsor:   Chongqing Medical University
    Recruiting

  • Conditions:   Colorectal Cancer;   Pancreatic Adenocarcinoma;   Gastric Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Bladder Cancer;   Melanoma;   Ovarian Cancer;   Adrenocortical Cancer;   Breast Cancer;   Other Cancer
    Intervention:  
    Sponsor:   Quantgene Inc.
    Recruiting

  • Conditions:   Bone Marrow Failure Syndrome;   Thalassemia;   Sickle Cell Disease;   Diamond Blackfan Anemia;   Acquired Neutropenia in Newborn;   Acquired Anemia Hemolytic;   Acquired Thrombocytopenia;   Hemophagocytic Lymphohistiocytoses;   Wiskott-Aldrich Syndrome;   Chronic Granulomatous Disease;   Common Variable Immunodeficiency;   X-linked Lymphoproliferative Disease;   Severe Combined Immunodeficiency;   Hurler Syndrome;   Mannosidosis;   Adrenoleukodystrophy
    Interventions:   Drug: Thiotepa--single daily dose;   Drug: Thiotepa--escalated dose
    Sponsor:   University of Florida
    Recruiting

  • Condition:   Primary Aldosteronism Due to Aldosterone Producing Adenoma
    Interventions:   Procedure: AVS performed with no intraprocedural rapid cortisol assay;   Procedure: AVS performed plus intraprocedural rapid cortisol assay
    Sponsor:   University Hospital Padova
    Not yet recruiting

  • Condition:   Adrenal Insufficiency
    Intervention:   Other: Patient education
    Sponsors:   Wuerzburg University Hospital;   Medical University of Graz, Austria;   Medical practice for Endocrinology in Oldenburg, Germany;   Charite University, Berlin, Germany;   University Hospital, Frankfurt, Germany;   Endocrinology in Charlottenburg, Berlin, Germany;   University Hospital Munich, Germany;   University Hospital of Rostock, Germany
    Recruiting

  • Condition:   Hyperaldosteronism
    Intervention:   Drug: Clarithromycin
    Sponsors:   University Hospital Padova;   DMG Paris Descartes
    Not yet recruiting

  • Conditions:   Primary Aldosteronism;   Hypertension
    Intervention:   Procedure: Endovascular chemical Ablation of Adrenal Gland
    Sponsor:   Third Military Medical University
    Recruiting

  • Conditions:   Primary Hyperaldosteronism;   Primary Hyperaldosteronism Due to Adrenal Adenoma
    Interventions:   Procedure: Endoscopic ultrasound guided radiofrequency ablation;   Device: ultrasound
    Sponsors:   University College, London;   Queen Mary University of London;   British Heart Foundation;   University of Cambridge;   Cambridge University Hospitals NHS Foundation Trust;   Barts & The London NHS Trust;   University College London Hospitals
    Recruiting

  • Conditions:   Adrenal Gland Neoplasm;   Hypertension;   Bone Diseases, Metabolic;   Cardiovascular Disease;   Hyperinsulinemia
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Adrenocortical Carcinoma
    Intervention:   Drug: Cabozantinib
    Sponsors:   M.D. Anderson Cancer Center;   Exelixis
    Recruiting

  • Conditions:   Adrenal Insufficiency;   Cirrhosis;   Spur Cell Anemia;   Lecithin Acyltransferase Deficiency
    Intervention:   Drug: Cosyntropin
    Sponsor:   University of Virginia
    Recruiting

  • Conditions:   Sickle Cell Disease;   Thalassemia;   High Risk Hematologic Disorders;   Cerebral Adrenoleukodystrophy;   Inherited Metabolic Disorders
    Intervention:   Procedure: Blood and Marrow Transplant
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Conditions:   Cushing's Disease;   Cushing Syndrome;   Cushing Disease
    Interventions:   Other: Cushing's QoL (Quality of Life Questionnaire);   Other: Nottingham Health Profile (NHP);   Other: Hospital Anxiety and Depression Scale (HADS);   Other: Perceived Stress Scale (PSS);   Other: Barratt's Impulsivity Scale (BIS);   Other: Beck Depression Inventory (BDI);   Other: State-Trait Anxiety Inventory (STAI);   Other: State Food Craving Questionnaire-State (FCQ-S);   Other: Trait Food Craving Questionnaire-Trait (FCQ-T);   Other: Visual Analogue Scale (VAS);   Other: Sensitivity to Reinforcement of Addictive and other Primary Rewards (STRAP-R) food variant
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Condition:   Cushing Syndrome
    Intervention:  
    Sponsors:   University of Roma La Sapienza;   Federico II University;   University of Palermo;   University of Florence;   Ospedali Riuniti Ancona;   University of Padova
    Recruiting

  • Conditions:   Genitourinary Cancer;   Adrenocortical Carcinoma;   Non-urothelial Bladder;   Non-urothelial Upper Tract;   Penile Cancer;   Non-adenocarcinoma Prostate Cancer;   Refractory Germ-cell
    Interventions:   Drug: Ipilimumab;   Drug: Nivolumab
    Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb
    Recruiting

  • Conditions:   Rheumatoid Arthritis;   Adrenal Insufficiency
    Intervention:  
    Sponsor:   University of Edinburgh
    Recruiting

  • Condition:   Endogenous Cushing's Syndrome
    Interventions:   Drug: Levoketoconazole;   Drug: Placebo
    Sponsor:   Cortendo AB
    Recruiting

  • Condition:   X-Linked Adrenoleukodystrophy
    Intervention:  
    Sponsor:   NeuroVia, Inc.
    Recruiting

  • Conditions:   Congenital Adrenal Hyperplasia;   CAH - Congenital Adrenal Hyperplasia
    Intervention:   Drug: SPR001
    Sponsor:   Spruce Biosciences
    Recruiting

  • Condition:   Adrenocortical Carcinoma
    Intervention:   Drug: Cabazitaxel
    Sponsors:   Azienda Ospedaliera Spedali Civili di Brescia;   San Luigi Gonzaga Hospital
    Recruiting

  • Condition:   Addison Disease
    Intervention:   Drug: Dexamethasone
    Sponsor:   Göteborg University
    Not yet recruiting

  • Condition:   Cushing Syndrome
    Intervention:  
    Sponsors:   Göteborg University;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Leiden University Medical Center
    Recruiting

  • Condition:   X-Linked Adrenoleukodystrophy
    Intervention:   Drug: Sobetirome (NV1205)
    Sponsor:   NeuroVia, Inc.
    Recruiting

  • Conditions:   Adrenocortical Carcinoma;   Peritoneal Carcinomatosis
    Interventions:   Drug: Cisplatin;   Drug: Sodium thiosulfate;   Procedure: Cytoreductive surgery
    Sponsor:   Columbia University
    Recruiting

  • Condition:   Endocrine Disease
    Interventions:   Other: Data Collection;   Behavioral: Follow Up
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting

  • Condition:   Cushing Syndrome
    Interventions:   Drug: ATR-101;   Drug: Placebo
    Sponsor:   Millendo Therapeutics US, Inc.
    Recruiting

  • Condition:   Congenital Adrenal Hyperplasia
    Intervention:   Drug: Hydrocortisone
    Sponsor:   Diurnal Limited
    Recruiting

  • Conditions:   Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Condition:   Partial Mineralocorticoid Deficiency
    Interventions:   Drug: Oral Fludrocortisone (enteral);   Drug: Placebo Oral Tablet
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Recruiting

  • Conditions:   Primary Aldosteronism;   Hyperaldosteronism
    Intervention:   Procedure: adrenalectomy
    Sponsors:   Queen Mary University of London;   National Institute for Health Research, United Kingdom;   WBIC), Cambridge. University of Cambridge Addenbrookes Hospital, Cambridge CB2 2QQ;   Robertson Centre for Biostatistics University of Glasgow Glasgow G12 8QQ;   Barts and the London School of Medicine and Dentistry W Smithfield London - City of London EC1A 7BE
    Recruiting

  • Conditions:   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia;   Cushing Syndrome;   Growth Hormone Deficiency;   Acromegaly;   Primary Hyperaldosteronism
    Intervention:   Other: 27 hour subcutaneous fluid sampling
    Sponsors:   Haukeland University Hospital;   Karolinska Institutet;   University Hospitals Bristol NHS Foundation Trust;   Evaggelismos Hospital, Greece
    Recruiting

  • Conditions:   Adrenal Cortex Carcinoma;   Alveolar Soft Part Sarcoma;   Central Nervous System Neoplasm;   Childhood Clear Cell Sarcoma of Soft Parts;   Clear Cell Sarcoma of Soft Tissue;   Ewing Sarcoma;   Hepatoblastoma;   Hepatocellular Carcinoma;   MITF Positive;   Osteosarcoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Alveolar Soft Part Sarcoma;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Hepatocellular Carcinoma;   Recurrent Malignant Central Nervous System Neoplasm;   Recurrent Malignant Solid Neoplasm;   Recurrent Osteosarcoma;   Recurrent Renal Cell Carcinoma;   Recurrent Rhabdomyosarcoma;   Recurrent Soft Tissue Sarcoma;   Recurrent Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma;   Recurrent Thyroid Gland Medullary Carcinoma;   Refractory Ewing Sarcoma;   Refractory Malignant Central Nervous System Neoplasm;   Refractory Malignant Solid Neoplasm;   Refractory Osteosarcoma;   Refractory Rhabdomyosarcoma;   Refractory Soft Tissue Sarcoma;   Refractory Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma;   Renal Cell Carcinoma;   Rhabdomyosarcoma;   Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma;   Solid Neoplasm;   Thyroid Gland Medullary Carcinoma;   Wilms Tumor
    Interventions:   Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Adrenal Gland Metastases
    Intervention:   Radiation: Stereotactic Body Radiation Therapy
    Sponsor:   Istituto Clinico Humanitas
    Recruiting

  • Conditions:   Acinar Cell Carcinoma;   Adenoid Cystic Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bartholin Gland Transitional Cell Carcinoma;   Bladder Adenocarcinoma;   Cervical Adenocarcinoma;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Desmoid-Type Fibromatosis;   Endometrial Transitional Cell Carcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Gastric Undifferentiated Carcinoma;   Gastrointestinal Stromal Tumor;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Testicular Sex Cord-Stromal Tumor;   Metaplastic Breast Carcinoma;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Minimally Invasive Lung Adenocarcinoma;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Ovarian Transitional Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Rare Disorder;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Carcinoma
    Interventions:   Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Adrenal Insufficiency;   Growth Disorder;   Endocrine Diseases;   Metabolic Disease;   Bone Diseases, Metabolic
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Carcinoma of Unknown Primary Origin;   Kidney Medullary Carcinoma;   Malignant Germ Cell Tumor;   Metastatic Adrenal Gland Pheochromocytoma;   Metastatic Malignant Solid Neoplasm;   Metastatic Paraganglioma;   Metastatic Penile Carcinoma;   Paraganglioma;   Skin Squamous Cell Carcinoma;   Small Cell Carcinoma;   Stage IV Adrenal Cortex Carcinoma AJCC v7;   Stage IV Penile Cancer AJCC v7;   Stage IV Renal Cell Cancer AJCC v7;   Unresectable Solid Neoplasm;   Vascular Neoplasm
    Interventions:   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Other: Questionnaire Administration
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Adrenocortical Carcinoma
    Intervention:   Drug: Pembrolizumab
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Merck Sharp & Dohme Corp.
    Recruiting

  • Condition:   Primary Aldosteronism Due to Aldosterone Producing Adenoma
    Intervention:   Device: Renal Sympathetic Denervation
    Sponsor:   Henan Institute of Cardiovascular Epidemiology
    Recruiting

  • Conditions:   Advanced Solid Tumors (Part A/B/C/D);   Non-small Cell Lung Cancer (Part E);   Melanoma (Part E);   Squamous Cell Cancer of the Head and Neck (Part E);   Triple Negative Breast Cancer (Part F);   Adrenocortical Carcinoma (Part G);   Mesothelioma (Part G);   High-circulating Myeloid-derived Suppressor Cells (Part H)
    Interventions:   Drug: IPI-549;   Drug: Nivolumab
    Sponsor:   Infinity Pharmaceuticals, Inc.
    Recruiting

  • Condition:   Cushing's Syndrome Cardiomyopathy
    Intervention:   Drug: Tadalafil
    Sponsor:   Andrea M. Isidori
    Recruiting

  • Condition:   X-linked Adrenoleukodystrophy
    Intervention:   Dietary Supplement: vitamin D3
    Sponsors:   Stanford University;   National Institute of Neurological Disorders and Stroke (NINDS);   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   ALD Connect, Inc.
    Recruiting

  • Condition:   Adrenal Incidentalomas
    Interventions:   Procedure: Laparoscopic surgical removal of the adrenal tumor;   Drug: Standardized medical treatment of hypertension by SAHR
    Sponsor:   University Hospital, Bordeaux
    Recruiting

  • Condition:   Primary Aldosteronism
    Interventions:   Other: Adrenalectomy;   Drug: mineralocorticoid receptor antagonist
    Sponsors:   Vanderbilt University;   Brigham and Women's Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting

  • Conditions:   Adrenal Incidentaloma;   Adrenocortical Carcinoma
    Intervention:  
    Sponsors:   University Medical Center Groningen;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   VU University Medical Center;   Radboud University;   Leiden University Medical Center;   Maastricht University Medical Center;   UMC Utrecht;   Erasmus Medical Center;   Martini Hospital Groningen;   Canisius-Wilhelmina Hospital;   Diakonessenhuis, Utrecht;   Isala;   Haga Hospital;   St. Antonius Hospital;   Kennemer Gasthuis;   Maxima Medical Center;   Medical Center Alkmaar;   Medical Centre Leeuwarden;   Meander Medical Center;   Medisch Spectrum Twente;   Onze Lieve Vrouwe Gasthuis;   Rijnstate Hospital;   Elisabeth-TweeSteden Ziekenhuis;   Tergooi Hospital;   Vlietland Ziekenhuis;   Scheper Hospital;   Flevo Hospital
    Recruiting

  • Conditions:   Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn;   Alpha-Mannosidosis;   Sanfilippo Mucopolysaccharidoses
    Intervention:   Biological: DUOC-01
    Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation
    Recruiting

  • Conditions:   Mucopolysaccharidosis Disorders;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Alpha-Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Glycoprotein Metabolic Disorders;   Sphingolipidoses;   Recessive Leukodystrophies;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann-Pick B;   Niemann-Pick C Subtype 2;   Sphingomyelin Deficiency;   Peroxisomal Disorders;   Adrenoleukodystrophy With Cerebral Involvement;   Zellweger Syndrome;   Neonatal Adrenoleukodystrophy;   Infantile Refsum Disease;   Acyl-CoA Oxidase Deficiency;   D-Bifunctional Enzyme Deficiency;   Multifunctional Enzyme Deficiency;   Alpha-methylacyl-CoA Racmase Deficiency;   Mitochondrial Neurogastrointestingal Encephalopathy;   Severe Osteopetrosis;   Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation);   Inherited Metabolic Disorders
    Interventions:   Biological: Stem Cell Transplantation;   Drug: IMD Preparative Regimen;   Drug: Osteopetrosis Only Preparative Regimen;   Drug: Osteopetrosis Haploidentical Only Preparative Regimen;   Drug: cALD SR-A (Standard-Risk, Regimen A);   Drug: cALD SR-B (Standard-Risk, Regimen B);   Drug: cALD HR-D (High-Risk, Regimen C);   Drug: cALD HR-D (High-Risk, Regimen D)
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Condition:   Cushing Syndrome
    Interventions:   Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Adrenal Gland Neoplasms
    Interventions:   Other: FDG positron emission tomography;   Other: Iodometomidate imaging
    Sponsors:   Wuerzburg University Hospital;   Charite University, Berlin, Germany;   Heinrich-Heine University, Duesseldorf;   University Hospital, Essen;   Johannes Gutenberg University Mainz;   Ludwig-Maximilians - University of Munich;   Hannover Medical School;   University of Leipzig;   University of Florence;   University of Padova;   Cambridge University Hospitals NHS Foundation Trust;   University Medical Center Nijmegen;   Uppsala University Hospital;   Assistance Publique - Hôpitaux de Paris;   University of Vienna
    Recruiting

  • Conditions:   Pheochromocytoma;   Adrenal Incidentaloma
    Intervention:   Procedure: Removal of adrenal tumor
    Sponsor:   University of Aarhus
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Alzheimer Disease;   Oxidative Stress;   Adrenocortical Hyperfunction
    Intervention:  
    Sponsor:   Raffaele Antonelli Incalzi
    Recruiting

  • Condition:   Chronic Adrenal Insufficiency
    Intervention:  
    Sponsor:   Shire
    Recruiting

  • Conditions:   Endocrine Tumors;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Adrenocortical Tumor
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Conditions:   Adrenal Tumors;   Adrenocortical Carcinoma;   Cushing Syndrome;   Conn Syndrome;   Pheochromocytoma
    Intervention:  
    Sponsors:   University of Wuerzburg;   Deutsche Krebshilfe e.V., Bonn (Germany);   German Federal Ministry of Education and Research
    Recruiting

  • Condition:   Adrenocortical Carcinoma
    Intervention:  
    Sponsor:   University of Wuerzburg
    Recruiting

  • Condition:   Adrenocortical Carcinoma
    Intervention:  
    Sponsors:   University of Wuerzburg;   Deutsche Krebshilfe e.V., Bonn (Germany)
    Recruiting

  • Condition:   Adrenal Gland Neoplasm
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Adrenal Insufficiency;   Pituitary Neoplasm;   Obesity
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Cushing Syndrome
    Interventions:   Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting


PaidClinicalTrials.orgPaidClinicalTrials.org